Dollar General (DG) marked its 27th consecutive year of same-store sales growth in fiscal 2016. It followed this milestone up with a beat on both the top and bottom lines during its first quarter of 2017, with comps once again growing – but by only about 0.7%. As I was sifting through the retail carnage, Dollar General was one of the companies that stood out as above average, so I decided....More>>>
I. Introduction – The Capital Raise Details
We begin with a quick review of the capital raise.
Tesla’s (NASDAQ:TSLA) agreement with its underwriters called for issuance of 1,335,978 shares, with an over-allotment option of up to 200,281 shares, all to be sold at $262.
That option was exercised, so the total share issuance was 1,536,259, resulting in total proceeds....More>>>
401(k) Savers May Have to Fund Trumps Corporate Tax Cut
Texas Judge Denies Emergency Request to Block DOL Fiduciary Rule
Did Warren Overreach in Blasting Annuity Sales Perks?
Advisors’ bonuses are not maintaining the same pace as industry profit growth, according to the New York State Comptroller’s office.
The latest results of the yearly survey find that....More>>>
Stocks rose this week after tax reform returned to the fore and geopolitical tensions appeared to ebb.
The S&P 500 rose 0.8% this week after dropping 0.3% to2,348.69 today, while the Dow Jones Industrial Average advanced 0.5% this week after declining 30.95 points, or 0.2%, to 20,547.76. The Nasdaq Composite gained 1.8% this week after dipping 0.1% to 5,910.52....More>>>
By way of arriving at matters concerning Tesla (NASDAQ:TSLA), indulge me a bit while I discuss the weather.
I’m writing this from the foothills of the Gallatin Range, where the temperature has been on the icy side of zero Fahrenheit for a good part of the past several weeks.
Click to enlarge
(Bozone Amber Ale and the Bridger Mountains)
The frigid weather put me....More>>>
Pick a small-cap biotech company, any small-cap biotech company, and you could be picking the winning lottery ticket if its cutting-edge research pans out. And if it doesn’t? Well, then you could end up like StemCells (STEM), which reported lackluster trial data and announced that it would be winding down. Maxim’s Jason Kolbert and Jason McCarthy explain:
Surprising news came....More>>>
Michael E. Lewitt
Gold sold off sharply since the election based on the belief that President-elect Trump will bring higher growth. This sell-off makes little sense for those who understand that gold is an investment in monetary policy failure and the destruction of paper currencies. Central banks remain hell-bent on printing money and creating inflation in order to deal with epic levels....More>>>
Shares of Procter & Gamble (PG) are soaring today after the consumer-staples giant reported better-than-expected earnings.
Procter & Gamble reported an adjusted profit of $1.08 a share, beating forecasts for $1.06, despite sales coming at at $16.86 billion, below forecasts for $16.94 billion. It also cited the strong dollar as a possible headwind.
Organovo Holdings Inc. (NASDAQ: ONVO) shares saw a handy gain on Tuesday after the bio-printer announced that it received a strong consumer response from its second tissue service. Specifically, the ExVive Human Kidney Tissue launched in September, which uses Organovos 3D bio-printed kidney tissue to study the effects of drug exposure through toxicology panels and transporter studies.